Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05290064
Other study ID # 220002
Secondary ID 22-DK-0002
Status Recruiting
Phase N/A
First received
Last updated
Start date November 4, 2022
Est. completion date February 28, 2025

Study information

Verified date June 7, 2024
Source National Institutes of Health Clinical Center (CC)
Contact Nan Zhai, C.R.N.P.
Phone (301) 827-3324
Email nan.zhai@nih.gov
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Protocol Number: 22DK0002 Title: Effects of Ultra-processed versus Unprocessed Diets on Energy Metabolism Background: Many diets worldwide include both processed and unprocessed foods. Researchers want to study the effects these foods have on a person s health. Objective: To study how different diets affect a person s health and metabolism. Eligibility: Adults aged 18 60 without diabetes who have stable weight and can exercise. Design: Participants will be screened with: Medical history Physical exam Heart tests Resting energy expenditure (to determine calorie needs) Blood and urine tests 20-minute stationary bicycle session Food, diet, and mental health questionnaires Participants will stay at NIH for 4 weeks. They will receive 3 meals a day and may eat as little or as much as they want. The diet will change each week. Their weight will be recorded daily. They will ride a stationary bicycle daily. Each week, they will do the following: Spend 1 day in a special room that assesses their metabolism Have 24-hour urine collections Give skin and fecal samples Repeat some screening tests Have scans to measure body fat Complete computerized behavior tasks Wear an activity monitor to track physical activity Wear a glucose monitor. A sensor will be inserted under the skin with a small needle. It will be replaced weekly. Take taste tests. They will swish water and flavored liquids around in their mouth and pick which ones had a non-neutral taste. They will also compare liquids for which ones taste better. Participation will last for 4 weeks. Sponsoring Institution: National Institute of Diabetes and Digestive and Kidney Diseases ...


Description:

This is a randomized crossover study of adult volunteers to determine the health effects of four different diets varying in non-beverage energy density, hyperpalatable foods, as well as the degree, extent, and purpose of processing according to the NOVA classification system. Objectives/Endpoints: Primary Aim: To determine differences in health effects during four 1-week test diets. Secondary Aims: To determine differences in mean eating rate (grams per minute) and palatability of meals between the four 1-week test diets. Exploratory Aims: Several exploratory measurements are planned to help comprehensively phenotype the effects of the test diets and are intended to be hypothesis-generating.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date February 28, 2025
Est. primary completion date December 24, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility - INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: - Provision of signed and dated informed consent form - Adults age 18-60 years, male and female - Weight stable (< +/- 5 % body weight change over past 6 months) as determined by volunteer report - Body mass index (BMI) > =20 kg/m2 - Body weight > = 53 kg - Able to complete daily bouts of stationary cycling at a moderate rate and intensity with a HR equal to or greater than 0.3(SqrRoot) (220-age-HRrest)+HRrest but not exceeding 0.4(SqrRoot) (220-age-HRrest)+HRrest and no signs of arrhythmia - Willingness to comply with all study procedures and Lifestyle Considerations for the duration of the study per the discretion of the PI. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: - Evidence of diseases or conditions that may influence appetite (e.g., cancer, diabetes, alterations of smell or taste post COVID-19), or other conditions at the discretion of the PI and/or study team). - Taking prescription medications or other drugs that may influence appetite (including, but not limited to, diet/weight-loss medication or other medications at the discretion of the PI and/or study team) - Positive pregnancy test or lactation as determined by volunteer report (women only) - Participating in a regular exercise program (> 2h/week of vigorous activity) as determined by volunteer report - Hematocrit < 37% (women only) - Hematocrit < 40% (men only) - Caffeine consumption > 300 mg/day as determined by volunteer report - Alcohol consumption > 3 drinks per day for men or > 2 drinks per day for women as determined by volunteer report - Regular use of tobacco (smoking or chewing), amphetamines, cocaine, heroin, or marijuana over past 6 months as determined by volunteer report. Subjects may also be excluded based on a urine drug test. - Psychological conditions as determined by volunteer report such as (but not limited to) eating disorders, depression, bipolar disorders, that would be incompatible with safe and successful participation in this study, as determined by investigators - Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, food allergies) or a reported dislike of a significant fraction of the study foods - Volunteers unwilling or unable to give informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Ultra-processed food, high energy density
Ultra-processed diet that is high in non-beverage energy density and low in hyperpalatable foods
Ultra-processed food, both low
Ultra-processed diet that is low in both non-beverage energy density and hyperpalatable foods
Ultra-processed food, both high
Ultra-processed diet that is high in both non-beverage energy density and hyperpalatable foods
Unprocessed food diet
Unprocessed diet that is low in both non-beverage energy density and hyperpalatable foods

Locations

Country Name City State
United States National Institutes of Health Clinical Center Bethesda Maryland

Sponsors (1)

Lead Sponsor Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Energy Metabolism (kcal per day) Energy Metabolism averaged over 7 days for each diet, measured in kilocalories (kcal) per day. Primary comparisons will be between UPF HH & UPF HL, UPF HL & UPF LL, UPF LL & UNF LL, UPF HH & UNF LL. Four 1-week diets
Secondary Meal eating rate (grams per minute) This will be determined by the measured duration of the meals along with the measured mass of food consumed. Four 1-week diets
Secondary Meal palatability This will be measured via questionnaires using visual analogue scales. Four 1-week diets
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2